Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Open
-
A Phase I Randomised, Single-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of AZD1613 Following Multiple Ascending Dose Administration In Participants With Autosomal Dominant Polycystic Kidney Disease
Rochester, MN
A study to investigate safety, tolerability, and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosomal dominant polycystic kidney disease (ADPKD).
-
A Pilot Study For Managing Depressive Symptoms In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Rochester, MN
The purpose of this study is to assess the feasibility of REJUVENATE (DNT) or CC for short-term improvement of mood and quality of life (QoL) in ADPKD. Since mood disorders and pain may be chronic conditions which wax and wane over time, we have included an education or attention control arm to assess the effect of time/attention on these responses.
-
A Study To Determine The Prevalence And Clinical Characteristics Associated With PKD1 Gene Variant Groups In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Jacksonville, FL
Rochester, MN
The purpose of this study is to estimate the prevalence of PKD1 gene variant groups in the ADPKD population and describe the demographic and clinical characteristics of ADPKD by PKD1 gene variant group.
Closed for Enrollment
-
"An Early Phase 1, Exploratory Study Evaluating Diffusion Magnetic Resonance Imaging To Assess Baseline Differences Between Adults With Autosomal Dominant Polycystic Kidney Disease (ADPKD) And Healthy Subjects, And Disease Progression In Adults With ADPKD”
Rochester, MN
The purpose of this study is to assess the ability of 18F-sodium fluoride positron emission tomography ( 18F-NaF PET)/computed tomography (CT) and Diffusion magnetic resonance imaging (MRI) to differentiate between healthy subjects and ADPKD subjects at baseline
-
A Phase I Randomised, Single-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of AZD1613 Following Multiple Ascending Dose Administration In Participants With Autosomal Dominant Polycystic Kidney Disease
Jacksonville, FL
A study to investigate safety, tolerability, and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosomal dominant polycystic kidney disease (ADPKD).
.